Derniers essais

EudraCT Number: 2004-000940-26

Sponsor Protocol Number: CASM981C2314

Start Date: 2004-09-24

Sponsor Name: Novartis Pharma

Full Title: A 22-week randomized, multicenter, parallel-group, double-blind study to compare a pimecrolimus 1 % (Elidel) twice daily (b.i.d.) maintenance dosing regimen to a once daily (o.d.) maintenance dosin...

Medical condition: Atopic dermatitis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: FI (Completed) AT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2004-000022-75

Sponsor Protocol Number: CV131-169

Start Date: 2004-09-24

Sponsor Name: Bristol-Myers Squibb International Corporation

Full Title: Irbesartan Versus Placebo in Combination with Standard Cardiovascular Protection ACE-I Therapy with Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk

Medical condition: Albuminuria in hypertensive subjects at increased cardiovascular risk.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: LT (Completed) LV (Completed) IT (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-001731-28

Sponsor Protocol Number: C LF 23-0121 0401

Start Date: 2004-09-24

Sponsor Name: FOURNIER Laboratories Ireland

Full Title: A double-blind, 3-arm study on weight loss with combination of micronised fenofibrate 267 mg and metformin 1700 mg per day compared to metformin 1700 mg and placebo, at 6 months, in obese patients,...

Medical condition: Obesity

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: FI (Completed)

Trial results: View results

EudraCT Number: 2004-001562-41

Sponsor Protocol Number: H4Z-MC-GJAD

Start Date: 2004-09-24

Sponsor Name: Lilly SA

Full Title: Efectos del Arzoxifeno en la incidencia de fracturas vertebrales y en la incidencia de cáncer de mama invasivo en las mujeres posmenopáusicas con osteoporosis o con baja densidad ósea Effects of ...

Medical condition: Incidencia de fracturas vertebrales e incidencia de cáncer de mama invasivo en mujeres posmenopáusicas con osteoporosis o con baja densidad ósea

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-000955-40

Sponsor Protocol Number: CI-1008-152

Start Date: 2004-09-23

Sponsor Name: Pfizer Global Research & Development

Full Title: A Placebo-Controlled Study of Pregabalin in Elderly Patients With Generalized Anxiety Disorder

Medical condition: Generalized Anxiety Disorder

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: LV (Completed)

Trial results: View results

EudraCT Number: 2004-001281-40

Sponsor Protocol Number: 20040615

Start Date: 2004-09-23

Sponsor Name: Gottfries Clinic

Full Title: Long-term study with the staphylococcus vaccine Staphypan in treatment of patients with fibromyalgia and chronic fatigue syndrome

Medical condition: Fibromyalgia M79.0 + Chronic fatigue syndrome F48.0

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-000954-22

Sponsor Protocol Number: CI-1008-100

Start Date: 2004-09-23

Sponsor Name: Pfizer Global Research & Development

Full Title: A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders

Medical condition: Generalized Anxiety Disorder

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: LV (Completed)

Trial results: View results

EudraCT Number: 2004-001538-18

Sponsor Protocol Number: 603-PG-PSC-74

Start Date: 2004-09-23

Sponsor Name: LETI Pharma GmbH

Full Title: A randomised, double blinded, placebo controlled multicentre study for the efficacy and safety of Depigoid birch pollen

Medical condition: Patients have to suffer from IgE mediated allergic rhinits, rhinoconjunctivitis +/- asthma due to sensitization again birch pollen.

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10036019		LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

EudraCT Number: 2004-000424-32

Sponsor Protocol Number: 045

Start Date: 2004-09-23

Sponsor Name: Merck Sharp & Dohme BV

Full Title: A Multicenter, Open, Noncomparative Study to Estimate the Safety, Tolerability, and Efficacy of Caspofungin Acetate in the Treatment of Adults with Invasive Candida Infections (Excluding Patients w...

Medical condition: Non-Blood Invasive Candidiasis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: View results

EudraCT Number: 2004-000113-18

Sponsor Protocol Number: CLIC477D2302

Start Date: 2004-09-23

Sponsor Name: Novartis Farmacéutica, S.A.

Full Title: A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of licarbazepine 750-2500 mg/d combined with risperidone in the treatment of mani...

Medical condition: Bipolar I disorder, manic and mixed episodes

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed) HU (Completed) FI (Prematurely Ended)

Trial results: View results

Derniers essais

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue